On October 1, 2019 Stealth BioTherapeutics Corp (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, reported that Reenie McCarthy, Chief Executive Officer, will present at the 2019 Cantor Global Healthcare Conference on Wednesday, October 2, 2019 at 5:20 p.m. ET in New York (Press release, Stealth Biologics, OCT 1, 2019, View Source [SID1234540002]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the presentation will be available on the Investors & News section of Stealth’s website at https://investor.stealthbt.com/. A replay of the webcast will be archived on Stealth’s website for 30 days following the event.